Clinical results in the treatment of American leishmaniasis with oral and intravenous amphotericin.
D000666:Amphotericin B; D000935:Antifungal Agents / Q000628:therapy*; D005659:Fungicides, Industrial; D006801:Humans; D007896:Leishmaniasis; D016773:Leishmaniasis, Cutaneous; D007897:Leishmaniasis, Mucocutaneous / Q000628:therapy*
D000935:Antifungal Agents; D005659:Fungicides, Industrial; D000666:Amphotericin B
FUNGICIDES/therapy; LEISHMANIASIS, MUCOCUTANEOUS/therapy